[go: up one dir, main page]

MX9700860A - Inhibicion de la biosintesis de leucotrienos con derivados de urea. - Google Patents

Inhibicion de la biosintesis de leucotrienos con derivados de urea.

Info

Publication number
MX9700860A
MX9700860A MX9700860A MX9700860A MX9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A MX 9700860 A MX9700860 A MX 9700860A
Authority
MX
Mexico
Prior art keywords
leukotriene biosynthesis
inhibition
urea derivatives
compound
pharmaceutical composition
Prior art date
Application number
MX9700860A
Other languages
English (en)
Other versions
MXPA97000860A (es
Inventor
Stephen L Crooks
Bryon A Merrill
Paul D Wightman
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Publication of MX9700860A publication Critical patent/MX9700860A/es
Publication of MXPA97000860A publication Critical patent/MXPA97000860A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un método para inhibir la biosíntesis de leucotrienos, que incluye administrar un compuesto de la formula I en donde M, R, R', R" y n son como se definen aquí. También una composicion farmacéutica que incluye ese compuesto y el uso de ese compuesto en la fabricacion de una composicion farmacéutica para inhibir la biosíntesis de leucotrienos.
MXPA/A/1997/000860A 1994-08-04 1997-02-03 Inhibicion de la biosintesis de leucotrienos con derivados de urea MXPA97000860A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US286017 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
US4556432 1995-05-31
US08455643 1995-05-31
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (2)

Publication Number Publication Date
MX9700860A true MX9700860A (es) 1997-10-31
MXPA97000860A MXPA97000860A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
IL114646A0 (en) 1995-11-27
FI970452A0 (fi) 1997-02-03
AU3091795A (en) 1996-03-04
NZ290236A (en) 1998-12-23
EP0777471A1 (en) 1997-06-11
BR9508521A (pt) 1997-10-28
CZ31297A3 (en) 1997-09-17
FI970452L (fi) 1997-02-03
IL114646A (en) 2000-02-29
EP0777471B1 (en) 2002-11-27
ES2185708T3 (es) 2003-05-01
AU685980B2 (en) 1998-01-29
SK11097A3 (en) 1997-09-10
CZ287034B6 (en) 2000-08-16
DE69528984D1 (de) 2003-01-09
PL318539A1 (en) 1997-06-23
WO1996003983A1 (en) 1996-02-15
DE69528984T2 (de) 2003-09-04
NO970477L (no) 1997-03-14
JPH10503771A (ja) 1998-04-07
PL180668B1 (pl) 2001-03-30
SK282777B6 (sk) 2002-12-03
FI970452A7 (fi) 1997-02-03
DK0777471T3 (da) 2003-03-17
NO315786B1 (no) 2003-10-27
PT777471E (pt) 2003-04-30
HUT76830A (en) 1997-11-28
CA2196701A1 (en) 1996-02-15
ATE228359T1 (de) 2002-12-15
NO970477D0 (no) 1997-02-03

Similar Documents

Publication Publication Date Title
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MX9308199A (es) Inhibidores de enzima.
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
BR0109703A (pt) Derivados de piperazina
ES2098921T3 (es) Composiciones de cetoconazol de uso topico.
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
ES2185155T3 (es) Agentes conservantes de madera para la proteccion subsiguiente.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
ES2171428T3 (es) Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos.
KR960705810A (ko) 퀴나졸린 유도체(quinazoline derivatives)
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
MX9703634A (es) Derivados de dibencimidazol antibacterianos.
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR004474A1 (es) Compuestos de 10-aminoalifatil-dibenz [b,f]oxepinas antineurodegenerativamente activas, utiles para el tratamiento de estados neurodegenerativos y composiciones farmaceuticas que los contienen
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
SE9504662D0 (sv) New compounds
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
MX9700860A (es) Inhibicion de la biosintesis de leucotrienos con derivados de urea.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees